Tumoral, quasitumoral and pseudotumoral lesions of the superficial and somatic soft tissue: new entities and new variants of old entities recorded during the last 25 years. Part V: excerpta IIi
Bisceglia, M.; Fisher, C.; Suster, S.; Kazakov, D.V.; Cooper, K.; Michal, M.
Pathologica 96(6): 481-495
2004
ISSN/ISBN: 0031-2983 PMID: 15792376 Document Number: 569851
Document emailed within 1 workday
Related Documents
Genevay, M.; Coindre, J-Michel.; Guillou, L. 2003: Recent entities in soft tissue tumor pathology. Part 2 Annales de Pathologie 23(2): 135-148Dimopoulos, M.A.; Kastritis, E.; Terpos, E. 2013: Non-secretory myeloma: one, two, or more entities? Oncology 27(9): 930-932
Derbes, S.J.; deShazo, R.D. 1985: Urticaria and angioedema: new insights and new entities Comprehensive Therapy 11(6): 52-59
Burda, D. 1996: IRS rules against 'shell' joint entities Modern Healthcare 26(41): 32
Pallarito, K. 1996: Emerging health entities devouring capital Modern Healthcare 26(50): 68
Mosley, J.W. 1972: Viral hepatitis: a group of epidemiologic entities Canadian Medical Association Journal 106(Suppl): 427-434
Piascik, M.M. 1991: Research and development of drugs and biologic entities American Journal of Hospital Pharmacy 48(10 Suppl 1): S4-S13
Kaufman, N.S. 1998: Market dominance of PHO entities is key to achieving PHO success Healthcare Financial Management: Journal of the Healthcare Financial Management Association 52(8): 79-80
Armata, J. 1977: Lymphosarcoma and reticulosarcoma in children as separate entities Polski Tygodnik Lekarski 32(3): 117-119
Sorel, L.; de Biolley, D.; Mechler, L. 1978: Computerized axial tomography and epileptic entities Acta Neurologica Belgica 78(4): 232-241
Assanelli, D.; Lewinter, M.; Shabetai, R. 1989: Physiology and physiopathology of the pericardium: 2 underestimated entities Cardiologia 34(8): 671-677
Gibowski, M.; Burda, A. 1976: Serum immunoglobulins in selected disease entities Przeglad Dermatologiczny 63(2): 129-132
Kira, J. 1999: DPB 1 *0501-associated opticomyelitis and atopic myelitis: novel disease entities Rinsho Shinkeigaku 39(1): 19-20
Coleman, G.; Nelson, J. 1989: A review of dental radiographic interpretation, Part II: Differential diagnosis of radiopacities, mixed radiolucent-radiopaque lesions, maxillary sinus disease, and soft tissue calcifications Compendium 10(8): 434-437; 440
Lv, Y.; Deng, Y.; Liu, M.; Cui, Y.; Lu, Q. 2016: Short Text Classification of EMR Based on Entities and Dependency Parser Zhongguo Yi Liao Qi Xie Za Zhi 40(4): 245-249
Prus, V.šn.; Kardum, Že. 2016: Clinical Entities and Characteristics of Pain in Patients with Rheumatic Diseases Reumatizam 63(Suppl 1): 23-26
Velasco, M.; Hurtado, C.; Brahm, J. 1990: Anti-hepatitis C viral antibodies in different pathological entities in Chile Revista Medica de Chile 118(8): 895-896
Fearing, M.K.; Spar, M.D.; Kahn, M.J. 1998: Chronic thrombotic thrombocytopenic purpura masquerading as other disease entities Journal of the Louisiana State Medical Society: Official Organ of the Louisiana State Medical Society 150(1): 29-31
Turleau, C.; de Grouchy, J. 1988: Microcytogenetics 1988. Mendelian disease entities related to microdeletions, duplications, translocations Annales de Pediatrie 35(10): 711-718
Zuccala', A.; Cianci, R.; Presta, P.; Fuiano, G. 2009: Nephroangiosclerosis and ischemic nephropathy: two different entities or two renal manifestations of the same systemic cardiovascular disease? Giornale Italiano di Nefrologia: Organo Ufficiale Della Societa Italiana di Nefrologia 26(3): 299-309